<Suppliers Price>

Dipotassium hexachloroiridate(2-)

Names

[ CAS No. ]:
16920-56-2

[ Name ]:
Dipotassium hexachloroiridate(2-)

[Synonym ]:
POTASSIUM CHLOROIRIDATE
dipotassiumhexachloroiridate
EINECS 240-976-7
Iridate(2-), hexachloro-, potassium (1:2)
Potassium hexachloroiridate(IV),Ir min
POTASSIUM HEXACHLOROIRIDATA(IV)
MFCD00011369
hexachloro-,dipotassium,(OC-6-11)-Iridate
POTASSIUM HEXACHLOROIRIDATE
Iridium potassium chloride
Dipotassium hexachloroiridate(2-)
dipotassium,(oc-6-11)-iridate(2-hexachloro
POTASSIUM HEXACHLOROIRIDATE(IV)

Chemical & Physical Properties

[ Density]:
3,546 g/cm3

[ Melting Point ]:
>385 °C(lit.)

[ Molecular Formula ]:
Cl6IrK2

[ Molecular Weight ]:
483.132

[ Exact Mass ]:
480.703430

[ LogP ]:
4.13700

[ Stability ]:
Stable. Incompatible with strong reducing agents.

MSDS

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H302 + H312 + H332-H315-H319-H335

[ Precautionary Statements ]:
P261-P280-P305 + P351 + P338

[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves

[ Hazard Codes ]:
Xn

[ Risk Phrases ]:
R20/21/22

[ Safety Phrases ]:
S26-S36

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

Articles

Insertion of dGMP and dAMP during in vitro DNA synthesis opposite an oxidized form of 7,8-dihydro-8-oxoguanine.

Nucleic Acids Res. 27(2) , 496-502, (1999)

Oxidative damage to DNA bases commonly resultsin the formation of oxidized purines, particularly 7,8-dihydro-8-oxoguanine (8-oxoG) and 7,8-dihydro-8-oxoadenine (8-oxoA), the former being a well-known ...

Proton-coupled electron-transfer oxidation of phenols by hexachloroiridate(IV).

Inorg. Chem. 47(24) , 11458-60, (2008)

One-electron oxidation of phenol, 2,4,6-trimethylphenol, and 2,6-dimethylphenol by [IrCl(6)](2-) in aqueous solution has a simple pH dependence, indicating slow bimolecular oxidation of ArOH and faste...

Pseudohalide anions reveal a novel extracellular site for potentiators to increase CFTR function.

Br. J. Pharmacol. 167(5) , 1062-75, (2012)

There is great interest in the development of potentiator drugs to increase the activity of the cystic fibrosis transmembrane conductance regulator (CFTR) in cystic fibrosis. We tested the ability of ...


More Articles


Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.